IMMUNOPLANT for Newly Diagnosed Multiple Myeloma

NCT06376526 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

BIOLOGICAL: Linvoseltamab

Sponsor

Dickran Kazandjian, MD

Collaborators

[object Object]